Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

2 results

  1. SOCIAL QUESTIONS|health|pharmaceutical industry · EUROPEAN UNION|EU institutions and European civil service|EU office or agency|European Medicines Agency · PRODUCTION, TECHNOLOGY AND RESEARCH|research and intellectual property|research
    forbairt chliniciúil Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'forbairt chliniciúil, bailíochtú agus iontráil sa mhargadh i réimse na ngalar tógálach, na ngalar neamhchoitianta aimpléiseach, na ngalar néarmheathlúcháin agus eile...' Reference "Rialachán Tarmligthe (AE) 2021/1078 lena bhforlíontar Rialachán (AE) 2021/523 ó Pharlaimint na hEorpa agus ón gComhairle lena leagtar amach na treoirlínte infheistíochta maidir le Ciste InvestEU,CELEX:32021R1078/GA"
    taighde cliniciúil Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'Chuir rialálaithe idirnáisiúnta in iúl go raibh gá leis an gclár oibre taighde cliniciúil a fheabhsú chun fianaise láidir ar cháilíocht, sábháilteacht agus éifeachtúlacht táirgí íocshláinte a ghiniúint.' Reference "Rialachán (AE) 2022/123 maidir le ról atreisithe don Ghníomhaireacht Leigheasra Eorpach in ullmhacht agus bainistiú géarchéimeanna do tháirgí íocshláinte agus d’fheistí leighis,CELEX:32022R0123/GA"
    clinical development | clinical research
    en
    Definition studies in human subjects, either patients or healthy volunteers, including clinical trials designed to determine human pharmacology (PK/PD), and exploratory or confirmatory safety and efficacy studies, for pre- or post-authorisation activities including risk-management programmes Reference "EMA. 'European Medicines Agency Guidance for Applicants seeking scientific advice and protocol assistance' (14.11.2022). 14 October 2022 EMA/4260/2001 Rev. 14 Scientific Evidence Generation Department"
  2. SOCIAL QUESTIONS|health|pharmaceutical industry
    forbairt chliniciúil dhéanach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Comment <<<_not_supplied_>>>
    in einer späten Phase erfolgende Entwicklung | Late-Stage-Entwicklung
    de
    late-stage clinical development | late-stage development
    en
    Definition "pharmaceutical development which primarily seeks to demonstrate efficacy, safety, and cost-effectiveness and corresponds to phases 2b and 3 clinical trials" Reference "COM-Terminology Coordination, based on: VCLS. 'Late-Stage Clinical Development' (7.9.2023)"
    stade de développement clinique avancé | développement avancé
    fr
    Definition "développement de médicaments correspondant à la phase II randomisée et à la phase III des essais cliniques" Reference "COM-FR, d'après le site de Gustave Roussy - Cancer Campus, Grand Paris : Décryptage > Les essais cliniques (31.5.2023)"
    Comment Les différentes phases des essais cliniques sont les suivantes :- la phase I consiste à évaluer la sécurité d’emploi d’une nouvelle molécule ;- la phase II a pour objectif de tester l’efficacité du produit et de déterminer la dose optimale (posologie) et ses effets indésirables éventuels ;- la phase III permet de comparer l’efficacité thérapeutique de la molécule au traitement de référence (lorsque celui-ci existe) ou bien à un placebo (lorsqu'aucune thérapie n’existe).